Fresenius plays market momentum to increase convertible bond
German healthcare firm Fresenius increased the size of a convertible bond it completed on Tuesday to €500m from a planned €375m, after the deal was multiple times oversubscribed. The bonds were issued alongside a purchase of call options by Fresenius which made the deal equity-neutral, ruling out dilution for shareholders.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts